Fonar ROE 2006-2019 | FONR
Current and historical return on equity (ROE) values for Fonar (FONR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Fonar ROE for the three months ending June 30, 2019 was 12.35%.
| Fonar ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2019-06-30 | $0.01B | $0.12B | 12.47% |
| 2019-03-31 | $0.02B | $0.11B | 17.55% |
| 2018-12-31 | $0.02B | $0.11B | 17.48% |
| 2018-09-30 | $0.02B | $0.11B | 19.39% |
| 2018-06-30 | $0.02B | $0.10B | 20.49% |
| 2018-03-31 | $0.02B | $0.09B | 18.18% |
| 2017-12-31 | $0.02B | $0.09B | 22.75% |
| 2017-09-30 | $0.02B | $0.09B | 24.28% |
| 2017-06-30 | $0.02B | $0.08B | 25.94% |
| 2017-03-31 | $0.02B | $0.08B | 28.04% |
| 2016-12-31 | $0.02B | $0.07B | 25.20% |
| 2016-09-30 | $0.02B | $0.07B | 24.90% |
| 2016-06-30 | $0.02B | $0.06B | 26.32% |
| 2016-03-31 | $0.01B | $0.06B | 25.69% |
| 2015-12-31 | $0.01B | $0.06B | 25.12% |
| 2015-09-30 | $0.01B | $0.05B | 23.88% |
| 2015-06-30 | $0.01B | $0.05B | 22.45% |
| 2015-03-31 | $0.01B | $0.05B | 20.94% |
| 2014-12-31 | $0.01B | $0.05B | 21.39% |
| 2014-09-30 | $0.01B | $0.05B | 22.35% |
| 2014-06-30 | $0.01B | $0.05B | 23.39% |
| 2014-03-31 | $0.01B | $0.04B | 24.54% |
| 2013-12-31 | $0.01B | $0.04B | 23.23% |
| 2013-09-30 | $0.01B | $0.04B | 25.20% |
| 2013-06-30 | $0.01B | $0.04B | 28.00% |
| 2013-03-31 | $0.00B | $0.04B | 21.92% |
| 2012-12-31 | $0.00B | $0.01B | 32.65% |
| 2012-09-30 | $0.00B | $0.01B | 36.36% |
| 2012-06-30 | $0.00B | $0.01B | 42.11% |
| 2012-03-31 | $0.00B | $0.01B | 36.36% |
| 2011-12-31 | $0.00B | $0.01B | 57.14% |
| 2011-09-30 | $0.00B | $0.01B | 150.00% |
| 2011-06-30 | $0.00B | $0.01B | -200.00% |
| 2011-03-31 | $0.00B | $-0.00B | -50.00% |
| 2010-12-31 | $0.00B | $-0.00B | -19.05% |
| 2010-09-30 | $-0.00B | $-0.01B | 17.39% |
| 2010-06-30 | $-0.00B | $-0.01B | 52.17% |
| 2010-03-31 | $-0.00B | $-0.01B | 60.00% |
| 2009-12-31 | $-0.00B | $-0.01B | 47.06% |
| 2009-09-30 | $0.00B | $-0.01B | 0.00% |
| 2009-06-30 | $0.00B | $-0.00B | -53.33% |
| 2009-03-31 | $-0.01B | $-0.00B | 125.00% |
| 2008-12-31 | $-0.01B | $-0.00B | 360.00% |
| 2008-09-30 | $-0.01B | $-0.01B | 5600.00% |
| 2008-06-30 | $-0.01B | $-0.00B | -430.77% |
| 2008-03-31 | $-0.02B | $0.00B | -246.15% |
| 2007-12-31 | $-0.02B | $0.01B | -180.00% |
| 2007-09-30 | $-0.02B | $0.01B | -131.03% |
| 2007-06-30 | $-0.03B | $0.01B | -129.87% |
| 2007-03-31 | $-0.03B | $0.02B | -102.04% |
| 2006-12-31 | $-0.03B | $0.02B | -90.76% |
| 2006-09-30 | $-0.03B | $0.03B | -77.14% |
| 2006-06-30 | $-0.03B | $0.03B | -72.96% |
| 2006-03-31 | $-0.02B | $0.04B | -44.20% |
| 2005-12-31 | $-0.01B | $0.04B | -26.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.131B | $0.087B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $148.763B | 27.14 |
| Medtronic (MDT) | Ireland | $146.524B | 20.57 |
| Stryker (SYK) | United States | $76.003B | 25.56 |
| Boston Scientific (BSX) | United States | $57.941B | 27.35 |
| Baxter (BAX) | United States | $41.222B | 25.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.507B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $29.830B | 18.71 |
| Terumo (TRUMY) | Japan | $26.321B | 32.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.591B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.229B | 40.28 |
| ResMed (RMD) | United States | $20.909B | 38.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.758B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $17.275B | 0.00 |
| Insulet (PODD) | United States | $10.935B | 520.23 |
| Bio-Rad Laboratories (BIO) | United States | $10.601B | 50.88 |
| Hill-Rom Holdings (HRC) | United States | $6.921B | 20.39 |
| William Demant Holdings (WILYY) | Denmark | $6.665B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.539B | 12.19 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.420B | 0.00 |
| Haemonetics (HAE) | United States | $6.074B | 41.04 |
| Canopy Growth (CGC) | Canada | $5.519B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.382B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
| NuVasive (NUVA) | United States | $3.748B | 29.51 |
| ICU Medical (ICUI) | United States | $3.612B | 23.55 |
| Aurora Cannabis (ACB) | Canada | $3.385B | 0.00 |
| Neogen (NEOG) | United States | $3.373B | 56.45 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.275B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.046B | 0.00 |
| Quidel (QDEL) | United States | $2.573B | 24.42 |
| National Vision Holdings (EYE) | United States | $2.139B | 48.27 |
| Agios Pharmaceuticals (AGIO) | United States | $2.014B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.492B | 0.00 |
| InMode (INMD) | Israel | $1.468B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.144B | 22.91 |
| AtriCure (ATRC) | United States | $1.111B | 0.00 |
| Aphria (APHA) | $1.109B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $0.924B | 17.30 |
| NanoString Technologies (NSTG) | United States | $0.848B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.838B | 20.93 |
| TG Therapeutics (TGTX) | United States | $0.794B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.777B | 29.74 |
| Omeros (OMER) | United States | $0.687B | 0.00 |
| PetIQ (PETQ) | United States | $0.686B | 16.72 |
| LeMaitre Vascular (LMAT) | United States | $0.679B | 38.13 |
| Quanterix (QTRX) | United States | $0.631B | 0.00 |
| Cerus (CERS) | United States | $0.609B | 0.00 |
| Surmodics (SRDX) | United States | $0.531B | 55.41 |
| HEXO (HEXO) | $0.486B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.485B | 29.07 |
| Owens & Minor (OMI) | United States | $0.414B | 15.30 |
| MacroGenics (MGNX) | United States | $0.410B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.386B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.368B | 26.68 |
| Meridian Bioscience (VIVO) | United States | $0.366B | 12.59 |
| BioLife Solutions (BLFS) | United States | $0.302B | 122.92 |
| Zynex (ZYXI) | United States | $0.302B | 34.11 |
| Bovie Medical (APYX) | United States | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.247B | 0.00 |
| United Health Products (UEEC) | United States | $0.208B | 0.00 |
| Vapotherm (VAPO) | United States | $0.196B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.170B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.156B | 789.00 |
| Cytosorbents (CTSO) | United States | $0.138B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.134B | 0.00 |
| Female Health (VERU) | United States | $0.125B | 0.00 |
| Chimerix (CMRX) | United States | $0.114B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.113B | 0.00 |
| United-Guardian (UG) | United States | $0.089B | 22.60 |
| Chembio Diagnostics (CEMI) | United States | $0.076B | 0.00 |
| Nephros (NEPH) | United States | $0.066B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.061B | 0.00 |
| Surface Oncology (SURF) | United States | $0.052B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.044B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.022B | 0.00 |
| Senestech (SNES) | United States | $0.018B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.017B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.012B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.011B | 0.00 |
| Myomo (MYO) | United States | $0.009B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
